Aiming to grow by 15%-20% per annum: Alok S. Sheth, Director, Samrudh Pharmaceuticals

Samrudh Pharmacare has identified a highly lucrative and socially impactful growth vector by focusing on suppositories and ointments. While suppositories are heavily utilized globally, they remain an under-penetrated, "new concept" in the domestic Indian retail sector